Pathogenic gene mutations in IL36RN, which encodes the interleukin 36-receptor antagonist (IL36Ra), were reported as causative genetic defects in several generalized pustular psoriasis (GPP) cases in 2011 [1,2]. Later, we reported that "GPP without psoriasis vulgaris (PV)" patients had homozygous or compound heterozygous mutations in IL36RN, and only a small number of "GPP with PV" patients had IL36RN mutations [3,4]. Mutation of IL36RN has been associated with GPP in both its heterozygous and homozygous states.
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00306932607174,00302841026182,alsfakia@gmail.com
Αναζήτηση αυτού του ιστολογίου
Πληροφορίες
Ετικέτες
Τρίτη 6 Φεβρουαρίου 2018
An infant with generalized pustular psoriasis and geographic tongue had a heterozygous IL36RN mutation and IgG2 deficiency
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Small molecule inhibitor of the Wnt pathway (SM04755) as a potential topical treatment for psoriasisBackground: Psoriasis (PSO) is an autoimmune disease causing patches of thick, inflamed, scaly skin due to excessive proliferation of skin c...
-
Clinical and animal studies show that ethanol exposure and inflammation during pregnancy cause similar behavioral disturbances in the offspr...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.